ASH Stock Analysis
AS
Avoid
Based on Eyestock quantitative analysis, ASH`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly overvalued
Ashland, Inc. engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company is headquartered in Wilmington, Delaware and currently employs 3,900 full-time employees. The company serves customers in a range of consumer and industrial markets, including architectural coatings, automotive, construction, energy, food and beverage, nutraceuticals, personal care and pharmaceuticals. Its segments include life sciences, personal care, specialty additives, and intermediates. The life sciences segment includes pharmaceuticals, nutraceuticals and nutrition, and diagnostic films and agricultural chemicals. The personal care segment skin and sun care, hair care, oral care, home care, and others. The specialty additives segment includes coatings, construction, and energy. The intermediates segment produces and supplies butanediol (BDO), Tetrahydrofuran (THF), n-methyl-pyrrolidone (NMP) and gamma-butyrolactone (GBL, BLO) in addition to other downstream products. Its products include acrylates, aquaflow, biofunctionals, cellulosics, cyclodextrins, encapsulates, emollient esters, emulsifiers, and others.